(Circulation. 1995;91:2566-2572.)
© 1995 American Heart Association, Inc.
Articles |
From the Academic Medical Center, University of Amsterdam, Department of Clinical and Experimental Cardiology, Amsterdam (A.R.R.M., T.O., J.T.V., J.M.T.d.B., F.J.L.v.C., M.J.J.); the Department of Cardiology, St Antonius Hospital, Nieuwegein (A.R.R.M., N.M.v.H., J.J.A.M.D.); and the Interuniversity Cardiology Institute, Utrecht (J.M.T.d.B.), the Netherlands.
Correspondence to Tobias Opthof, Academic Medical Center, University of Amsterdam, Department of Clinical and Experimental Cardiology, PO Box 22700, 1100 DE Amsterdam, Netherlands.
Background Postinfarction ventricular tachycardias (VTs) may degenerate into ventricular fibrillation (VF), but this does not happen in all patients. The underlying mechanism is not exactly known, but dispersion of refractory periods is considered a major factor in both induction and persistence of reentrant arrhythmias in general. Hypertrophied, noninfarcted myocardium has altered electrophysiological characteristics. We hypothesized that noninfarcted ventricular tissue may provide the heterogeneities that cause the transition from VT into VF. Local fibrillation intervals, ie, the average interval between local activations during VF, have previously been shown to correlate well with local refractoriness in human and canine atrium and in porcine and canine ventricle and may therefore be used as an index of local refractoriness. This technique permits simultaneous assessment of refractoriness at multiple sites.
Methods and Results We measured local fibrillation intervals at 32 to 64 sites in the noninfarcted part of the left ventricle in patients undergoing antiarrhythmic surgery for symptomatic, drug-refractory, postinfarction ventricular tachyarrhythmias. The grid of electrodes (interelectrode distance, 7 mm) was attached to the epicardium of the left ventricle remote from the infarcted tissue. Group 1 consisted of 7 patients with hemodynamically tolerable sustained VT (VT group). Group 2 consisted of 7 patients with cardiac arrest and documented VF (VF group). With the patients on cardiopulmonary bypass, VF was induced by multiple premature stimulation. The VF interval was not significantly different in the two study groups (VT group, 136±5.5 ms; VF group, 129±3.4 ms, mean±SEM). However, spatial dispersion of the VF intervals (remote from the infarcted area) expressed as the coefficient of variation of VF intervals (SDx100/mean VF interval in each heart) was significantly larger in the VF group. It was 3.63±0.56 in the VF group and 1.55±0.40 in the VT group (mean±SEM; P<.01). Differences between the shortest and longest VF intervals in one and the same heart and the largest difference between two adjacent sites were also larger in the VF group (P<.02 and P<.05, respectively).
Conclusions This study shows larger dispersion in VF intervals and therefore suggests larger dispersion of refractory periods in parts of the myocardium remote from the infarction in patients with postinfarction VF than in patients with postinfarction VT.
Key Words: death, sudden fibrillation tachycardia
This article has been cited by other articles:
![]() |
T. Opthof In vivo dispersion in repolarization and arrhythmias in the human heart Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H77 - H78. [Full Text] [PDF] |
||||
![]() |
V. S. Chauhan, E. Downar, K. Nanthakumar, J. D. Parker, H. J. Ross, W. Chan, and P. Picton Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H79 - H86. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Circulation, May 17, 2005; 111(19): 2537 - 2549. [Full Text] [PDF] |
||||
![]() |
M. J Janse Electrophysiological changes in heart failure and their relationship to arrhythmogenesis Cardiovasc Res, February 1, 2004; 61(2): 208 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Camm, M.J. Janse, D.M. Roden, M.R. Rosen, J. Cinca, and S.M. Cobbe Congenital and acquired long QT syndrome Eur. Heart J., August 1, 2000; 21(15): 1232 - 1237. [PDF] |
||||
![]() |
A. Patwardhan, S. Moghe, K. Wang, and F. Leonelli Frequency modulation within electrocardiograms during ventricular fibrillation Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H825 - H835. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Moubarak, P. E. Karasik, R. D. Fletcher, and M. R. Franz High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation J. Am. Coll. Cardiol., February 1, 2000; 35(2): 422 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.P. Amlie Electrophysiological mechanisms involved in the increased mortality of patients with cardiac insufficiency Eur. Heart J., September 2, 1999; 20(18): 1290 - 1292. [PDF] |
||||
![]() |
F. L Burton and S. M Cobbe Effect of sustained stretch on dispersion of ventricular fibrillation intervals in normal rabbit hearts Cardiovasc Res, August 1, 1998; 39(2): 351 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Oikarinen, L Toivonen, and M Viitasalo Electrocardiographic measures of ventricular repolarisation dispersion in patients with coronary artery disease susceptible to ventricular fibrillation Heart, June 1, 1998; 79(6): 554 - 559. [Abstract] [Full Text] |
||||
![]() |
M. Nabauer and S. Kaab Potassium channel down-regulation in heart failure Cardiovasc Res, February 1, 1998; 37(2): 324 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gepstein, G. Hayam, and S. A. Ben-Haim Activation-Repolarization Coupling in the Normal Swine Endocardium Circulation, December 2, 1997; 96(11): 4036 - 4043. [Abstract] [Full Text] |
||||
![]() |
A. Tosaki and D. K. Das Extracellular Mg++ Manipulation Prevents the Proarrhythmic Activity of Cromakalim in Ischemic/Reperfused Diabetic Hearts J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 309 - 317. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |